Clinical trial

Benralizumab Efficacy in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With Exacerbation History

NCT02138916

Study summary

ClinicalTrials.gov

Benralizumab Efficacy in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With Exacerbation History

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention Benralizumab Arm A Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Benralizumab Arm B Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2014-06-13

PhasePHASE3

Conditions

Moderate to Very Severe Chronic Obstructive Pulmonary Diseaseunresolved

Interventions

Benralizumab Arm ADRUG

Benralizumab Arm BDRUG

PlaceboDRUG

Sponsors & collaborators

AstraZenecalead sponsor

MedImmune LLCcollaborator

Mapped research locations

Saint PetersburgRussia6 MoscowRussia5 MiamiFlorida, United States4 SeoulSouth Korea4 RichmondVirginia, United States4 YekaterinburgRussia4 YokohamaJapan4 SapporoJapan4 HoustonTexas, United States3 BarcelonaSpain3 CincinnatiOhio, United States3 OrlandoFlorida, United States3

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02138916 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.